Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial

Journal

  • The Lancet

    The Lancet 390 (10111), 2472-2480, 2017-12

    Elsevier BV

Citations (2)*help

See more

Report a problem

Back to top